Opaleye Management’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

Opaleye Management’s Portfolio CMTA Stock Details CMTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-400,130	Closed	-$10.4M	–	62
2019 Q1	$10.4M	Buy	400,130 +250,130	+167%	+$4.67M	2.89%	11
2018 Q4	$1.76M	Buy	150,000 +1,168	+0.8%	+$14.5K	0.66%	36
2018 Q3	$1.66M	Buy	+148,832	New	+$1.57M	0.42%	40

Opaleye Management's CMTA Position: Q2 2019 in Review

Opaleye Management sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q2 2019, closing a stake of 400,130 shares — an estimated $10.4M sold.

Opaleye Management first reported a position in CMTA in Q3 2018 and held it in 3 quarters. The position peaked at $10.4M in Q1 2019. 0 funds tracked by Wall St. Rank hold CMTA as of Q2 2019.

Opaleye Management reported no remaining Clementia Pharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
Opaleye Management sold 400,130 Clementia Pharmaceuticals Inc. shares in Q2 2019, an estimated $10.4M.
Opaleye Management first reported a position in Clementia Pharmaceuticals Inc. in Q3 2018 and held it in 3 quarters.
Opaleye Management's Clementia Pharmaceuticals Inc. position peaked at $10.4M in Q1 2019.
0 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q2 2019.

Based on Opaleye Management's 13F filing for Q2 2019, filed 14 Aug 2019.